drugset / Trial / NCT02172274
BI 10773 Administered as Oral Solution to Healthy Male Volunteers
NaSingle-groupOpen-labelTreatment
Summary
Study to determine the pharmacokinetics of BI 10773 and total radioactivity including excretion mass balance, excretion pathways and metabolism following the oral administration of \[14C\] BI 10773
Timeline
- Start
- 2008-06
- Primary completion
- 2008-07
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Empagliflozin | Small molecule | 50 mg | Oral |
Indications
No indication recorded.